Literature DB >> 19737164

Cardiovascular nursing on human genomics: what do cardiovascular nurses need to know about congestive heart failure?

Lorraine Frazier1, Shu-Fen Wung, Elizabeth Sparks, Cathy Eastwood.   

Abstract

This paper presents the main causes of heart failure (HF) and an update on the genetics studies on each cause. The review includes a delineation of the etiology and fundamental pathophysiology of HF and provides rational for treatment for the patient and family. Various cardiomyopathies are discussed, including primary cardiomyopathies, mixed cardiomyopathies, cardiomyopathies that involve altered cardiac muscle along with generalized multiorgan disorders, and various cardiovascular conditions, such as coronary artery disease (ischemic cardiomyopathy) and hypertension (hypertensive cardiomyopathy). A brief review of pharmacogenetics and HF is presented. The application of the genetic components of cardiomyopathy and pharmacogenetics is included to enhance cardiovascular nursing care.

Entities:  

Mesh:

Year:  2009        PMID: 19737164      PMCID: PMC2749227          DOI: 10.1111/j.1751-7117.2009.00039.x

Source DB:  PubMed          Journal:  Prog Cardiovasc Nurs        ISSN: 0889-7204


  25 in total

Review 1.  Problems of reporting genetic associations with complex outcomes.

Authors:  Helen M Colhoun; Paul M McKeigue; George Davey Smith
Journal:  Lancet       Date:  2003-03-08       Impact factor: 79.321

Review 2.  Genetic predisposition to heart failure.

Authors:  Michele Pasotti; Alessandra Repetto; Luigi Tavazzi; Eloisa Arbustini
Journal:  Med Clin North Am       Date:  2004-09       Impact factor: 5.456

Review 3.  Beta-blocker pharmacogenetics in heart failure.

Authors:  Jaekyu Shin; Julie A Johnson
Journal:  Heart Fail Rev       Date:  2008-04-24       Impact factor: 4.214

4.  Actin mutations in dilated cardiomyopathy, a heritable form of heart failure.

Authors:  T M Olson; V V Michels; S N Thibodeau; Y S Tai; M T Keating
Journal:  Science       Date:  1998-05-01       Impact factor: 47.728

5.  Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy.

Authors:  M Kamisago; S D Sharma; S R DePalma; S Solomon; P Sharma; B McDonough; L Smoot; M P Mullen; P K Woolf; E D Wigle; J G Seidman; C E Seidman
Journal:  N Engl J Med       Date:  2000-12-07       Impact factor: 91.245

6.  The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model.

Authors:  Christopher Semsarian; Imran Ahmad; Michael Giewat; Dimitrios Georgakopoulos; Joachim P Schmitt; Bradley K McConnell; Steven Reiken; Ulrike Mende; Andrew R Marks; David A Kass; Christine E Seidman; J G Seidman
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

Review 7.  Molecular genetics and genomics of heart failure.

Authors:  Choong-Chin Liew; Victor J Dzau
Journal:  Nat Rev Genet       Date:  2004-11       Impact factor: 53.242

8.  Frequency and phenotypes of familial dilated cardiomyopathy.

Authors:  E Grünig; J A Tasman; H Kücherer; W Franz; W Kübler; H A Katus
Journal:  J Am Coll Cardiol       Date:  1998-01       Impact factor: 24.094

Review 9.  The role of angiotensin-converting enzyme polymorphism in congestive heart failure.

Authors:  Mara Pilati; Mariantonietta Cicoira; Luisa Zanolla; Ilaria Nicoletti; Simone Muraglia; Piero Zardini
Journal:  Congest Heart Fail       Date:  2004 Mar-Apr

Review 10.  Beta-adrenoceptor polymorphisms and heart failure.

Authors:  Martin J Lohse
Journal:  Trends Mol Med       Date:  2004-02       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.